BioNTech ADR saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, rising from 66 to 79. Please watch ...

BioNTech SE (BNTX) reports a net profit for Q4 2024 amidst a challenging year, with strategic advancements in oncology and ...

Novavax has shared positive preliminary results from a real-world study of its JN.1-adapted COVID-19 vaccine. The SHIELD-Utah ...

Morgan Stanley analyst Terence Flynn maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of $140.00.

As in previous studies, the SHIELD study found health care workers who received the Novavax vaccine reported significantly ...

We recently published a list of 12 Best German Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where BioNTech SE (NASDAQ:BNTX) stands against other best German ...

Duality Biologics has begun (PDF) offering stock, wading into a market reeling from Presid | Duality Biologics has begun ...

Novavax (NVAX) announced preliminary results from the SHIELD-Utah study that showed Novavax’s COVID-19 Vaccine, Adjuvanted 2024-2025 Formula ...

BioNTech saw its share price increase by 11%, coinciding with significant market activity and major index gains. While the company itself did not have any significant news or announcements within ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

BioNTech has shown why it made small cell lung cancer (SCLC) a priority for its PD-L1xVEGF-A bispecific. The biotech linked BNT327 to a median overall survival (OS) of 16.8 months in a Chinese ...